Form 4: Guardant Health Director Steve Krognes Reports Stock Transaction
SEC Form 4
Director Steve Krognes reports a transaction involving Guardant Health common stock on April 30, 2024.
Summary
- On April 30, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving the company's common stock.
- Krognes acquired 154 shares of common stock at a price of $0.
- This acquisition was related to the vesting of restricted stock units.
- Following the transaction, Krognes directly owns 3,393 shares of common stock.
- Krognes also directly owns 4,012 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine stock transaction by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, allowing investors to monitor their trading activity.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant. |
| 06/30/2023 | First vesting date of the restricted stock unit award (25%). |
| 04/30/2024 | Date of the reported transaction (acquisition of 154 shares). |
| 05/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.